Quick Answer
TAO Synergies Inc. reported Research And Development Expense of $322.2 thousand for the year ending 2025.
- TAO Synergies Inc. showed a decrease of -79.8% in Research And Development Expense from 2024 to 2025.
- This data is from TAO Synergies Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $845.8 thousand | Q1 2020: $393.2 thousand | Q2 2020: $563.3 thousand | Q3 2020: $410.3 thousand | Q1 2021: $1.15 million | Q2 2021: $986.3 thousand | Q3 2021: $836.7 thousand | Q1 2022: $1.49 million | Q2 2022: $1.94 million | Q3 2022: $1.48 million | Q1 2023: $877.7 thousand | Q2 2023: $307.2 thousand | Q3 2023: $212.1 thousand | Q1 2024: $609.2 thousand | Q2 2024: $342.1 thousand | Q3 2024: $222.9 thousand | Q1 2025: $60.8 thousand | Q2 2025: $148.6 thousand | Q3 2025: $54.4 thousand.
- Over the full 7 years of available data (2019 to 2025), TAO Synergies Inc.'s Research And Development Expense has declined by 94.3%.
- Historical annual values: Fiscal year 2025: $322.2 thousand | Fiscal year 2024: $1.60 million | Fiscal year 2023: $1.97 million | Fiscal year 2022: $6.32 million | Fiscal year 2021: $4.34 million | Fiscal year 2020: $3.07 million | Fiscal year 2019: $5.67 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: